Literature DB >> 17987668

The relationship of 5HTT (SLC6A4) methylation and genotype on mRNA expression and liability to major depression and alcohol dependence in subjects from the Iowa Adoption Studies.

Robert A Philibert1, Harinder Sandhu, Nancy Hollenbeck, Tracy Gunter, William Adams, Anup Madan.   

Abstract

Serotonin Transporter (5HTT or SLC6A4) mRNA transcription is regulated by both genetic and epigenetic mechanisms. Unfortunately, despite intense scrutiny, the exact identity and contribution of each of these regulatory mechanisms, and their relationship to behavioral illness remain unknown. This lack of knowledge is critical because alterations in SLC6A4 function are posited to be central to a wide variety of CNS disorders. In order to address this shortcoming, we quantified 5HTTLPR genotype, SLC6A4 mRNA production and CpG methylation using biomaterial from 192 lymphoblast cell lines derived from subjects who participated in the latest wave of the Iowa Adoption Studies. We then analyzed the resulting data with respect to clinical characteristics. We confirmed prior findings that the short (s) 5HTTLPR allele is associated with lower amounts of mRNA transcription, but there was no significant effect of the "Long G" allele on mRNA transcription. We also found that CpG methylation was higher (P < 0.0008) and mRNA production (P < 0.0001) was lower in females as compared to males. Those subjects with a lifetime history of Alcohol Dependence had higher levels of SLC6A4 mRNA. There was a trend for an association of increased overall methylation with lifetime history of major depression. Finally, we confirm our prior findings that the exact levels of 5HTT mRNA expression are dependent on how it is measured. We conclude that both genetic variation and epigenetic modifications contribute to the regulation of SLC6A4 function and that more in-depth studies of the molecular mechanisms controlling gene activity and the relationship of these mechanisms to behavioral illness are indicated. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17987668      PMCID: PMC3643119          DOI: 10.1002/ajmg.b.30657

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  36 in total

1.  Meta-analysis of serotonin transporter polymorphisms and affective disorders.

Authors:  Francis E Lotrich; Bruce G Pollock
Journal:  Psychiatr Genet       Date:  2004-09       Impact factor: 2.458

2.  A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies.

Authors:  D K Lahiri; J I Nurnberger
Journal:  Nucleic Acids Res       Date:  1991-10-11       Impact factor: 16.971

3.  Serotonin transporter promoter polymorphism, peripheral indexes of serotonin function, and personality measures in families with alcoholism.

Authors:  Scott F Stoltenberg; Geoffrey R Twitchell; Gregory L Hanna; Edwin H Cook; Hiram E Fitzgerald; Robert A Zucker; Karley Y Little
Journal:  Am J Med Genet       Date:  2002-03-08

4.  A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA.

Authors:  K K Bucholz; R Cadoret; C R Cloninger; S H Dinwiddie; V M Hesselbrock; J I Nurnberger; T Reich; I Schmidt; M A Schuckit
Journal:  J Stud Alcohol       Date:  1994-03

5.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

Review 6.  Migraine and depression: biological aspects.

Authors:  V Glover; J Jarman; M Sandler
Journal:  J Psychiatr Res       Date:  1993 Apr-Jun       Impact factor: 4.791

Review 7.  Pharmacogenomics of alcohol response and addiction.

Authors:  Mary-Anne Enoch
Journal:  Am J Pharmacogenomics       Date:  2003

8.  Serotonin transporter gene and autism: a haplotype analysis in an Irish autistic population.

Authors:  J Conroy; E Meally; G Kearney; M Fitzgerald; M Gill; L Gallagher
Journal:  Mol Psychiatry       Date:  2004-06       Impact factor: 15.992

9.  Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree.

Authors:  Marquis P Vawter; Erick Ferran; Brandi Galke; Kathleen Cooper; William E Bunney; William Byerley
Journal:  Schizophr Res       Date:  2004-03-01       Impact factor: 4.939

10.  Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression.

Authors:  Dubravka Hranilovic; Jasminka Stefulj; Sibylle Schwab; Margitta Borrmann-Hassenbach; Margot Albus; Branimir Jernej; Dieter Wildenauer
Journal:  Biol Psychiatry       Date:  2004-06-01       Impact factor: 13.382

View more
  120 in total

1.  Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia.

Authors:  Tempei Ikegame; Miki Bundo; Naohiro Okada; Yui Murata; Shinsuke Koike; Hiroko Sugawara; Takeo Saito; Masashi Ikeda; Keiho Owada; Masaki Fukunaga; Fumio Yamashita; Daisuke Koshiyama; Tatsunobu Natsubori; Norichika Iwashiro; Tatsuro Asai; Akane Yoshikawa; Fumichika Nishimura; Yoshiya Kawamura; Jun Ishigooka; Chihiro Kakiuchi; Tsukasa Sasaki; Osamu Abe; Ryota Hashimoto; Nakao Iwata; Hidenori Yamasue; Tadafumi Kato; Kiyoto Kasai; Kazuya Iwamoto
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

Review 2.  Variation in the Serotonin Transporter Gene and Alcoholism: Risk and Response to Pharmacotherapy.

Authors:  Miles D Thompson; George A Kenna
Journal:  Alcohol Alcohol       Date:  2015-08-26       Impact factor: 2.826

3.  Gender differences in the genetic and environmental determinants of adolescent depression.

Authors:  Monica Uddin; Karestan C Koenen; Regina de Los Santos; Erin Bakshis; Allison E Aiello; Sandro Galea
Journal:  Depress Anxiety       Date:  2010-07       Impact factor: 6.505

4.  Serotonin transporter linked polymorphic region (5-HTTLPR) genotype moderates the longitudinal impact of early caregiving on externalizing behavior.

Authors:  Zoë H Brett; Kathryn L Humphreys; Anna T Smyke; Mary Margaret Gleason; Charles A Nelson; Charles H Zeanah; Nathan A Fox; Stacy S Drury
Journal:  Dev Psychopathol       Date:  2015-02

Review 5.  Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation.

Authors:  S Brummelte; E Mc Glanaghy; A Bonnin; T F Oberlander
Journal:  Neuroscience       Date:  2016-02-22       Impact factor: 3.590

6.  Serotonin transporter gene promoter polymorphism (5-HTTLPR) and alcohol use in general population: interaction effect with birth cohort.

Authors:  Mariliis Vaht; Liis Merenäkk; Jarek Mäestu; Toomas Veidebaum; Jaanus Harro
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

7.  DNA Methylation Across the Serotonin Transporter Gene Following Marital Separation: A Pilot Study.

Authors:  David A Sbarra; Chelsea C Cook; Karen Hasselmo; Muhammad S Noon; Matthias R Mehl
Journal:  Ann Behav Med       Date:  2019-11-09

8.  MAOA methylation is associated with nicotine and alcohol dependence in women.

Authors:  Robert A Philibert; Tracy D Gunter; Steven R H Beach; Gene H Brody; Anup Madan
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-07-05       Impact factor: 3.568

9.  Impact of child sex abuse on adult psychopathology: a genetically and epigenetically informed investigation.

Authors:  Steven R H Beach; Gene H Brody; Man Kit Lei; Frederick X Gibbons; Meg Gerrard; Ronald L Simons; Carolyn E Cutrona; Robert A Philibert
Journal:  J Fam Psychol       Date:  2013-02

10.  The loss of methyl-CpG binding protein 1 leads to autism-like behavioral deficits.

Authors:  Andrea M Allan; Xiaomin Liang; Yuping Luo; Changhui Pak; Xuekun Li; Keith E Szulwach; Dahua Chen; Peng Jin; Xinyu Zhao
Journal:  Hum Mol Genet       Date:  2008-04-01       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.